Moderna defends its COVID-19 vaccine after seven European nations restrict or recommend against the shot's use in young people over concerns of rare heart inflammation
Moderna officials defended the use of their company's COVID-19 vaccine in young people amid a string of European countries shelving it in young people
Germany joined Denmark, Iceland, Finland, France, Norway and Sweden in recommending against or restricting the use of the Moderna jab in young people
European countries are concerned about the increased risk young people face of developing heart inflammation after getting the shot
The Moderna shot is still the most effective in the U.S., though, and a recent study finds it is 58% effective at preventing infection, higher than any other jab
By Mansur Shaheen U.S. Deputy Health Editor For Dailymail.Com
Published: 13:25 EST, 12 November 2021 | Updated: 13:25 EST, 12 November 2021
Moderna is standing by its COVID-19 vaccine in the wake of concerns being raised around the world about the jab causing rare heart inflammation in young people.
Seven European nations have either restricted the use of the shot in adults under age 30 or have made a recommendation against its use, in recent weeks.
Data from Swedish public health officials found that young adults - particularly males - who received the shot were more likely to develop myocarditis than those that receive the Pfizer-BioNTech vaccine, spurring the decisions.
more
https://www.dailymail.co.uk/health/article-10195701/Moderna-defends-COVID-19-vaccine-recent-rare-heart-inflammation-concerns.html